Obesity R&D in 2024 & beyond: Key considerations in an increasingly competitive landscape

Norstella empowers stakeholders involved in obesity drug development to make informed decisions based on trusted industry data and expert insights. This infographic uses some of those data and insights to demonstrate the various complex factors that continue to impact obesity R&D, assess expectations for future development in this space, and emphasize how Norstella serves as a key partner for organizations that want to stay ahead of the evolving landscape to deliver life-saving treatments to patients.

obesity-rd

Our AI capabilities are built to evolve—transforming data into insight, insight into action, and action into impact.